

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.77344960 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.77344960 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.73593258 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.73593258 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.73593258 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.73593258 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 6.73593258 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.73593258 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.92400656 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.92167435 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.79748172 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.43454064 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.40761019 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.31629063 |
| 15 | detection of bacterium (GO:0016045) | 4.97630473 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.90354239 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.89125373 |
| 18 | response to peptidoglycan (GO:0032494) | 4.83011654 |
| 19 | response to host immune response (GO:0052572) | 4.73665775 |
| 20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.73665775 |
| 21 | respiratory burst (GO:0045730) | 4.61914856 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.57994225 |
| 23 | microglial cell activation (GO:0001774) | 4.54081551 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 4.51508510 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 4.42296341 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 4.36613636 |
| 27 | neutrophil mediated immunity (GO:0002446) | 4.33208099 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 4.29156616 |
| 29 | neutrophil activation (GO:0042119) | 4.26548217 |
| 30 | response to host (GO:0075136) | 4.26459395 |
| 31 | response to host defenses (GO:0052200) | 4.26459395 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.26459395 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.24960149 |
| 34 | response to interleukin-15 (GO:0070672) | 4.10776649 |
| 35 | positive regulation of interferon-alpha production (GO:0032727) | 4.10082310 |
| 36 | granulocyte activation (GO:0036230) | 4.09447731 |
| 37 | macrophage activation (GO:0042116) | 4.08969320 |
| 38 | regulation of antigen processing and presentation (GO:0002577) | 4.07295743 |
| 39 | * regulation of B cell receptor signaling pathway (GO:0050855) | 4.03936988 |
| 40 | positive regulation of mast cell activation (GO:0033005) | 4.02277174 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.99408470 |
| 42 | cellular response to interleukin-15 (GO:0071350) | 3.97909344 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.89739778 |
| 44 | cellular extravasation (GO:0045123) | 3.89141305 |
| 45 | regulation of interferon-alpha production (GO:0032647) | 3.88045879 |
| 46 | superoxide anion generation (GO:0042554) | 3.81277176 |
| 47 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.79546233 |
| 48 | * regulation of mast cell activation (GO:0033003) | 3.75762839 |
| 49 | type I interferon signaling pathway (GO:0060337) | 3.73882011 |
| 50 | cellular response to type I interferon (GO:0071357) | 3.73882011 |
| 51 | daunorubicin metabolic process (GO:0044597) | 3.72531567 |
| 52 | polyketide metabolic process (GO:0030638) | 3.72531567 |
| 53 | doxorubicin metabolic process (GO:0044598) | 3.72531567 |
| 54 | response to type I interferon (GO:0034340) | 3.72491943 |
| 55 | negative T cell selection (GO:0043383) | 3.72421611 |
| 56 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.71211593 |
| 57 | positive thymic T cell selection (GO:0045059) | 3.70250289 |
| 58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.66998543 |
| 59 | negative regulation of granulocyte differentiation (GO:0030853) | 3.66441820 |
| 60 | negative thymic T cell selection (GO:0045060) | 3.64637693 |
| 61 | pinocytosis (GO:0006907) | 3.63871091 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.63327863 |
| 63 | * regulation of mast cell degranulation (GO:0043304) | 3.58568006 |
| 64 | T cell migration (GO:0072678) | 3.54640080 |
| 65 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.53463299 |
| 66 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.53463299 |
| 67 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.52514884 |
| 68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.52381833 |
| 69 | positive regulation of mast cell degranulation (GO:0043306) | 3.52381833 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.51995613 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.49182361 |
| 72 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48846007 |
| 73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.46731019 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.44545247 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.42947456 |
| 76 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.40051270 |
| 77 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.38583310 |
| 78 | * regulation of mast cell activation involved in immune response (GO:0033006) | 3.38223344 |
| 79 | leukocyte aggregation (GO:0070486) | 3.34229581 |
| 80 | detection of external biotic stimulus (GO:0098581) | 3.33853245 |
| 81 | positive regulation of B cell differentiation (GO:0045579) | 3.32613513 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 3.31582788 |
| 83 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.31186506 |
| 84 | myeloid leukocyte mediated immunity (GO:0002444) | 3.28271645 |
| 85 | negative regulation of innate immune response (GO:0045824) | 3.26040771 |
| 86 | response to muramyl dipeptide (GO:0032495) | 3.24729732 |
| 87 | positive T cell selection (GO:0043368) | 3.24596010 |
| 88 | regulation of tolerance induction (GO:0002643) | 3.19640604 |
| 89 | myeloid leukocyte activation (GO:0002274) | 3.19083344 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.15721905 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.15617564 |
| 92 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.12701176 |
| 93 | B cell mediated immunity (GO:0019724) | 3.12349040 |
| 94 | defense response to protozoan (GO:0042832) | 3.11189216 |
| 95 | detection of other organism (GO:0098543) | 3.09693414 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.09349899 |
| 97 | T cell selection (GO:0045058) | 3.08234531 |
| 98 | germinal center formation (GO:0002467) | 3.07576850 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07181466 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02454324 |
| 101 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.02420378 |
| 102 | positive regulation of interferon-beta production (GO:0032728) | 3.00334575 |
| 103 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.98556099 |
| 104 | regulation of B cell differentiation (GO:0045577) | 2.95093664 |
| 105 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94597709 |
| 106 | detection of biotic stimulus (GO:0009595) | 2.94478441 |
| 107 | glycosphingolipid catabolic process (GO:0046479) | 2.93920990 |
| 108 | leukocyte degranulation (GO:0043299) | 2.93702318 |
| 109 | negative regulation of type 2 immune response (GO:0002829) | 2.93660636 |
| 110 | mast cell activation (GO:0045576) | 2.92924314 |
| 111 | thymic T cell selection (GO:0045061) | 2.90800034 |
| 112 | leukocyte mediated cytotoxicity (GO:0001909) | 2.90646418 |
| 113 | activated T cell proliferation (GO:0050798) | 2.89775422 |
| 114 | myeloid dendritic cell activation (GO:0001773) | 2.86617806 |
| 115 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.86019120 |
| 116 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84857114 |
| 117 | I-kappaB phosphorylation (GO:0007252) | 2.84280150 |
| 118 | dendritic cell migration (GO:0036336) | 2.84064814 |
| 119 | negative regulation of interleukin-12 production (GO:0032695) | 2.82819627 |
| 120 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.82281970 |
| 121 | negative regulation of interleukin-17 production (GO:0032700) | 2.80589830 |
| 122 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80556520 |
| 123 | neutrophil chemotaxis (GO:0030593) | 2.80071793 |
| 124 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79035854 |
| 125 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.78445270 |
| 126 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78188902 |
| 127 | leukotriene metabolic process (GO:0006691) | 2.77795014 |
| 128 | B cell receptor signaling pathway (GO:0050853) | 2.77769122 |
| 129 | * regulation of leukocyte degranulation (GO:0043300) | 2.77484590 |
| 130 | cellular response to interferon-beta (GO:0035458) | 2.76352646 |
| 131 | reactive oxygen species biosynthetic process (GO:1903409) | 2.75375753 |
| 132 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.74960342 |
| 133 | response to protozoan (GO:0001562) | 2.74681382 |
| 134 | dendritic cell chemotaxis (GO:0002407) | 2.71746947 |
| 135 | neutrophil migration (GO:1990266) | 2.70622785 |
| 136 | regulation of mononuclear cell migration (GO:0071675) | 2.70302067 |
| 137 | response to fungus (GO:0009620) | 2.69334403 |
| 138 | ceramide catabolic process (GO:0046514) | 2.68922309 |
| 139 | positive regulation of T cell migration (GO:2000406) | 2.67828060 |
| 140 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.67532175 |
| 141 | interferon-gamma production (GO:0032609) | 2.67496743 |
| 142 | * negative regulation of mast cell activation (GO:0033004) | 2.65235348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.81669731 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.68263798 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.70864501 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.59205634 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.52052919 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.93560600 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71844376 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65357950 |
| 9 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.56767665 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22317970 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.11948148 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.04860549 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.01244977 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87665128 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.72564389 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.72522928 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67982542 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.45597710 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.40619813 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35987481 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.29085354 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22208369 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18973382 |
| 24 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05076135 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02799099 |
| 26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.02542585 |
| 27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01917839 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94252589 |
| 29 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.92644634 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92140072 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.89467593 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84879917 |
| 33 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.84754991 |
| 34 | * MAF_26560356_Chip-Seq_TH2_Human | 1.81764284 |
| 35 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.77954949 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77737412 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75920983 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74415467 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74247947 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72077729 |
| 41 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71343260 |
| 42 | * MYB_26560356_Chip-Seq_TH2_Human | 1.70918396 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69795556 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68992618 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65337799 |
| 46 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64970427 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64222538 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64022103 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59615370 |
| 50 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55289511 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48875090 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47413376 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.45893037 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44483110 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44356433 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39751568 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39543576 |
| 58 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38391486 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37415228 |
| 60 | * MYB_26560356_Chip-Seq_TH1_Human | 1.36577755 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36320084 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34142133 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34098424 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31671898 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31167792 |
| 66 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30006748 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29989023 |
| 68 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.28202922 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27749150 |
| 70 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26238262 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25525084 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22976696 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22947289 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.19902635 |
| 75 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.19663856 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18115855 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17513554 |
| 78 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14162088 |
| 79 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14021972 |
| 80 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.13354158 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11583402 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08752563 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06740721 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03978293 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03818488 |
| 86 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03750701 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01117130 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00597952 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99556197 |
| 90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.99098009 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95846945 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95634418 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93770544 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93570414 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92134474 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91857582 |
| 97 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91054714 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89109187 |
| 99 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87541640 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87515757 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87452038 |
| 102 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.87304870 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87158830 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85387046 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83337020 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81923934 |
| 107 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.81672638 |
| 108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81499197 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80565860 |
| 110 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.79723149 |
| 111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.79113105 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78494185 |
| 113 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76776856 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73561157 |
| 115 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.72889782 |
| 116 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.72118589 |
| 117 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70636694 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68423303 |
| 119 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.67821990 |
| 120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67661632 |
| 121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.67430876 |
| 122 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.65578707 |
| 123 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.65239138 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65196715 |
| 125 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.64141965 |
| 126 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.63775653 |
| 127 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.63524346 |
| 128 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.62767111 |
| 129 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.62707671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.47627052 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.72953909 |
| 3 | MP0003436_decreased_susceptibility_to | 3.53163602 |
| 4 | MP0002419_abnormal_innate_immunity | 3.37380760 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.15222855 |
| 6 | MP0003172_abnormal_lysosome_physiology | 2.93192377 |
| 7 | MP0009785_altered_susceptibility_to | 2.91656502 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.86705688 |
| 9 | MP0006082_CNS_inflammation | 2.70754219 |
| 10 | MP0005025_abnormal_response_to | 2.70480299 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.63764109 |
| 12 | MP0003303_peritoneal_inflammation | 2.60133652 |
| 13 | MP0005671_abnormal_response_to | 2.53947197 |
| 14 | MP0001790_abnormal_immune_system | 2.52815596 |
| 15 | MP0005387_immune_system_phenotype | 2.52815596 |
| 16 | MP0001800_abnormal_humoral_immune | 2.45084976 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.42459720 |
| 18 | MP0002723_abnormal_immune_serum | 2.39319682 |
| 19 | MP0003724_increased_susceptibility_to | 2.37874963 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.35832434 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.33569865 |
| 22 | MP0005174_abnormal_tail_pigmentation | 2.30183506 |
| 23 | MP0001819_abnormal_immune_cell | 2.25939155 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.24361115 |
| 25 | MP0001853_heart_inflammation | 2.13856226 |
| 26 | MP0000685_abnormal_immune_system | 2.05630569 |
| 27 | MP0002405_respiratory_system_inflammati | 1.99110470 |
| 28 | MP0000015_abnormal_ear_pigmentation | 1.96562255 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.93021960 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.85272819 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.80654305 |
| 32 | MP0004510_myositis | 1.79495042 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.75647192 |
| 34 | MP0000716_abnormal_immune_system | 1.67248008 |
| 35 | MP0009764_decreased_sensitivity_to | 1.65741963 |
| 36 | MP0000343_altered_response_to | 1.62474875 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.59463651 |
| 38 | MP0005310_abnormal_salivary_gland | 1.58726190 |
| 39 | MP0002398_abnormal_bone_marrow | 1.58576371 |
| 40 | MP0003866_abnormal_defecation | 1.56929150 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.52442092 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.51740796 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.51535741 |
| 44 | MP0008469_abnormal_protein_level | 1.48052972 |
| 45 | MP0009840_abnormal_foam_cell | 1.46573818 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.44173174 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.40179496 |
| 48 | MP0003448_altered_tumor_morphology | 1.39396339 |
| 49 | MP0002429_abnormal_blood_cell | 1.37874870 |
| 50 | MP0000858_altered_metastatic_potential | 1.37494021 |
| 51 | MP0002722_abnormal_immune_system | 1.33737924 |
| 52 | MP0003690_abnormal_glial_cell | 1.33348166 |
| 53 | MP0008260_abnormal_autophagy | 1.31742960 |
| 54 | MP0003075_altered_response_to | 1.30136103 |
| 55 | MP0009278_abnormal_bone_marrow | 1.29295999 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.28691476 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.26094018 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.26094018 |
| 59 | MP0004947_skin_inflammation | 1.23651985 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.23029913 |
| 61 | MP0002933_joint_inflammation | 1.17931674 |
| 62 | MP0001851_eye_inflammation | 1.17299848 |
| 63 | MP0003828_pulmonary_edema | 1.14387420 |
| 64 | MP0002006_tumorigenesis | 1.13677375 |
| 65 | MP0000490_abnormal_crypts_of | 1.12925112 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.11025664 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.10385059 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.10355264 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.09559915 |
| 70 | MP0001873_stomach_inflammation | 1.09187946 |
| 71 | MP0008004_abnormal_stomach_pH | 1.08773573 |
| 72 | MP0010307_abnormal_tumor_latency | 1.05680627 |
| 73 | MP0002095_abnormal_skin_pigmentation | 1.04151457 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.04021652 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.01587785 |
| 76 | MP0005166_decreased_susceptibility_to | 1.01495212 |
| 77 | MP0005451_abnormal_body_composition | 0.99714786 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.98976416 |
| 79 | MP0002132_abnormal_respiratory_system | 0.96658336 |
| 80 | MP0005390_skeleton_phenotype | 0.96353627 |
| 81 | MP0003763_abnormal_thymus_physiology | 0.95973322 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.91967513 |
| 83 | MP0000371_diluted_coat_color | 0.89321149 |
| 84 | MP0009763_increased_sensitivity_to | 0.80951914 |
| 85 | MP0003795_abnormal_bone_structure | 0.76852511 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.75520519 |
| 87 | MP0004381_abnormal_hair_follicle | 0.74278965 |
| 88 | MP0003045_fibrosis | 0.73018910 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.72561685 |
| 90 | MP0000604_amyloidosis | 0.70720600 |
| 91 | MP0000249_abnormal_blood_vessel | 0.70467350 |
| 92 | MP0004883_abnormal_blood_vessel | 0.66998218 |
| 93 | MP0002254_reproductive_system_inflammat | 0.65737112 |
| 94 | MP0005164_abnormal_response_to | 0.64846266 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.64451006 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.63736722 |
| 97 | MP0004130_abnormal_muscle_cell | 0.62845238 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.62689577 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.62187591 |
| 100 | MP0003646_muscle_fatigue | 0.62149321 |
| 101 | MP0008007_abnormal_cellular_replicative | 0.60575328 |
| 102 | MP0001663_abnormal_digestive_system | 0.60173295 |
| 103 | MP0008874_decreased_physiological_sensi | 0.60088558 |
| 104 | MP0008058_abnormal_DNA_repair | 0.58580547 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.57074736 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.56981820 |
| 107 | MP0003186_abnormal_redox_activity | 0.56045753 |
| 108 | MP0006292_abnormal_olfactory_placode | 0.54987280 |
| 109 | MP0009697_abnormal_copulation | 0.53494098 |
| 110 | MP0002075_abnormal_coat/hair_pigmentati | 0.52870400 |
| 111 | MP0005409_darkened_coat_color | 0.52746470 |
| 112 | MP0003279_aneurysm | 0.52183712 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.51937502 |
| 114 | MP0000920_abnormal_myelination | 0.49550759 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.47509804 |
| 116 | MP0000609_abnormal_liver_physiology | 0.46780439 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.44695911 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.42089505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.21442556 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.12898151 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.75651419 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 5.23344909 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.95778117 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.79360322 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 4.63222847 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.57494290 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.40682998 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.40682998 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.40682998 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.21643526 |
| 13 | Myositis (HP:0100614) | 4.19821169 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 4.11603731 |
| 15 | Obstructive lung disease (HP:0006536) | 4.11603731 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.96517783 |
| 17 | Recurrent skin infections (HP:0001581) | 3.84423636 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.78773954 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.75642436 |
| 20 | Gingivitis (HP:0000230) | 3.73597415 |
| 21 | Orchitis (HP:0100796) | 3.67541609 |
| 22 | Increased IgE level (HP:0003212) | 3.66391231 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.62666501 |
| 24 | Optic neuritis (HP:0100653) | 3.62666501 |
| 25 | T lymphocytopenia (HP:0005403) | 3.51231945 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.48334617 |
| 27 | Abnormality of T cell number (HP:0011839) | 3.43996445 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.43085629 |
| 29 | Prostate neoplasm (HP:0100787) | 3.32528869 |
| 30 | Stomatitis (HP:0010280) | 3.19009688 |
| 31 | Agnosia (HP:0010524) | 3.17207486 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.17195263 |
| 33 | Chest pain (HP:0100749) | 3.09519255 |
| 34 | Petechiae (HP:0000967) | 3.07802964 |
| 35 | Abnormality of T cells (HP:0002843) | 3.06619416 |
| 36 | Increased IgM level (HP:0003496) | 3.06428763 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.02761327 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.02761327 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.02761327 |
| 40 | Disinhibition (HP:0000734) | 3.02399010 |
| 41 | Glomerulonephritis (HP:0000099) | 2.95751912 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.95689786 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.95689786 |
| 44 | Hypochromic anemia (HP:0001931) | 2.91251339 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91203937 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91203937 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.88384765 |
| 48 | Recurrent pneumonia (HP:0006532) | 2.83336994 |
| 49 | Meningitis (HP:0001287) | 2.82586210 |
| 50 | Hypochromic microcytic anemia (HP:0004840) | 2.80086055 |
| 51 | Basal ganglia calcification (HP:0002135) | 2.78692144 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.78575561 |
| 53 | Periodontitis (HP:0000704) | 2.76702440 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.70281504 |
| 55 | Lymphopenia (HP:0001888) | 2.69648491 |
| 56 | Axonal loss (HP:0003447) | 2.69570562 |
| 57 | Urticaria (HP:0001025) | 2.66882022 |
| 58 | Anorexia (HP:0002039) | 2.62998145 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.62191537 |
| 60 | Pulmonary embolism (HP:0002204) | 2.61870312 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.60142529 |
| 62 | Vasculitis (HP:0002633) | 2.59857368 |
| 63 | Chronic otitis media (HP:0000389) | 2.56579316 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.56469975 |
| 65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.56255787 |
| 66 | Cheilitis (HP:0100825) | 2.53051439 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.51900033 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.51574493 |
| 69 | Recurrent viral infections (HP:0004429) | 2.50604645 |
| 70 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.48754332 |
| 71 | Episodic fever (HP:0001954) | 2.48677598 |
| 72 | Pustule (HP:0200039) | 2.46174617 |
| 73 | Purpura (HP:0000979) | 2.44729450 |
| 74 | J-shaped sella turcica (HP:0002680) | 2.44272237 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.43694924 |
| 76 | Chromsome breakage (HP:0040012) | 2.40080512 |
| 77 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.40078361 |
| 78 | Cellulitis (HP:0100658) | 2.37755752 |
| 79 | Pulmonary infiltrates (HP:0002113) | 2.36956273 |
| 80 | Recurrent bronchitis (HP:0002837) | 2.35585070 |
| 81 | IgM deficiency (HP:0002850) | 2.33544829 |
| 82 | Osteomyelitis (HP:0002754) | 2.31333144 |
| 83 | Leukocytosis (HP:0001974) | 2.29465189 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.29136646 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.26915401 |
| 86 | Gingival bleeding (HP:0000225) | 2.26272163 |
| 87 | Gangrene (HP:0100758) | 2.26072022 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.25056786 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.22922677 |
| 90 | Microcytic anemia (HP:0001935) | 2.21839119 |
| 91 | Hemoptysis (HP:0002105) | 2.21411740 |
| 92 | Joint hemorrhage (HP:0005261) | 2.20274024 |
| 93 | Loss of speech (HP:0002371) | 2.18536398 |
| 94 | Pathologic fracture (HP:0002756) | 2.18467788 |
| 95 | Abnormality of eosinophils (HP:0001879) | 2.18383919 |
| 96 | Increased serum ferritin (HP:0003281) | 2.17329354 |
| 97 | Epistaxis (HP:0000421) | 2.14943045 |
| 98 | Gastrointestinal stroma tumor (HP:0100723) | 2.14347993 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13387616 |
| 100 | Thoracic kyphosis (HP:0002942) | 2.13026464 |
| 101 | Amyloidosis (HP:0011034) | 2.12524624 |
| 102 | Eosinophilia (HP:0001880) | 2.09106954 |
| 103 | Recurrent sinusitis (HP:0011108) | 2.09089642 |
| 104 | Albinism (HP:0001022) | 2.07198455 |
| 105 | IgG deficiency (HP:0004315) | 2.05264269 |
| 106 | Abnormality of the endocardium (HP:0004306) | 2.04886711 |
| 107 | Keratoconjunctivitis (HP:0001096) | 2.04831850 |
| 108 | Peritonitis (HP:0002586) | 2.04280668 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 2.02152269 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 2.00489131 |
| 111 | Hematochezia (HP:0002573) | 2.00089548 |
| 112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.99846665 |
| 113 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99459693 |
| 114 | Skin ulcer (HP:0200042) | 1.99317028 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 1.99237966 |
| 116 | Thick nail (HP:0001805) | 1.98084640 |
| 117 | Colitis (HP:0002583) | 1.98015083 |
| 118 | Malnutrition (HP:0004395) | 1.97665332 |
| 119 | Encephalitis (HP:0002383) | 1.97387053 |
| 120 | Polyneuropathy (HP:0001271) | 1.96500752 |
| 121 | Restrictive lung disease (HP:0002091) | 1.96428822 |
| 122 | Bone pain (HP:0002653) | 1.95725002 |
| 123 | Granulocytopenia (HP:0001913) | 1.95212231 |
| 124 | Arthralgia (HP:0002829) | 1.94962978 |
| 125 | Acute hepatic failure (HP:0006554) | 1.94612311 |
| 126 | Abnormality of the peritoneum (HP:0002585) | 1.93747612 |
| 127 | Arterial thrombosis (HP:0004420) | 1.92789373 |
| 128 | Upper motor neuron abnormality (HP:0002127) | 1.91162239 |
| 129 | Myocardial infarction (HP:0001658) | 1.86191556 |
| 130 | Glomerulopathy (HP:0100820) | 1.84368717 |
| 131 | Reduced antithrombin III activity (HP:0001976) | 1.79109398 |
| 132 | Keratitis (HP:0000491) | 1.76964495 |
| 133 | Nephritis (HP:0000123) | 1.76755395 |
| 134 | Clubbing of toes (HP:0100760) | 1.74850422 |
| 135 | Abnormality of the pleura (HP:0002103) | 1.73929314 |
| 136 | Spondylolisthesis (HP:0003302) | 1.71788965 |
| 137 | Chronic diarrhea (HP:0002028) | 1.71269322 |
| 138 | Duplicated collecting system (HP:0000081) | 1.71090583 |
| 139 | Abnormality of the thoracic spine (HP:0100711) | 1.70839613 |
| 140 | Sepsis (HP:0100806) | 1.69692488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.32265161 |
| 2 | IRAK3 | 3.76480102 |
| 3 | BLK | 3.43752003 |
| 4 | KIT | 3.16142952 |
| 5 | MAP3K14 | 3.03074070 |
| 6 | TGFBR2 | 2.93524046 |
| 7 | TXK | 2.59324632 |
| 8 | RIPK4 | 2.58287025 |
| 9 | MAP4K1 | 2.38479220 |
| 10 | TYK2 | 2.32261119 |
| 11 | TBK1 | 2.27580031 |
| 12 | TEC | 2.21863574 |
| 13 | GRK6 | 2.12169656 |
| 14 | CSF1R | 1.96488033 |
| 15 | SIK3 | 1.91204678 |
| 16 | IKBKB | 1.89996869 |
| 17 | MAP3K11 | 1.85972086 |
| 18 | BTK | 1.83787339 |
| 19 | TAOK3 | 1.80102977 |
| 20 | IKBKE | 1.74854932 |
| 21 | GRK7 | 1.71325903 |
| 22 | CLK1 | 1.68713400 |
| 23 | FES | 1.56271978 |
| 24 | ZAK | 1.54475371 |
| 25 | EIF2AK2 | 1.49040995 |
| 26 | JAK3 | 1.45989080 |
| 27 | TESK2 | 1.44867558 |
| 28 | ZAP70 | 1.44845286 |
| 29 | SYK | 1.44071764 |
| 30 | MAP2K3 | 1.43163936 |
| 31 | HCK | 1.43160334 |
| 32 | LYN | 1.36306413 |
| 33 | CDC42BPA | 1.35316805 |
| 34 | TAOK1 | 1.24922292 |
| 35 | NEK9 | 1.22670845 |
| 36 | CSK | 1.18107972 |
| 37 | TRPM7 | 1.16169778 |
| 38 | PIM2 | 1.15926464 |
| 39 | SIK2 | 1.15751461 |
| 40 | JAK1 | 1.15094712 |
| 41 | STK10 | 1.14819496 |
| 42 | NME2 | 1.11377276 |
| 43 | ITK | 1.06498669 |
| 44 | STK16 | 1.06337426 |
| 45 | LCK | 1.06102267 |
| 46 | MAP3K1 | 1.03485290 |
| 47 | KDR | 1.03362853 |
| 48 | BMPR1B | 1.03250220 |
| 49 | PRKD2 | 1.00527189 |
| 50 | TRIB3 | 1.00042531 |
| 51 | ADRBK2 | 0.99978987 |
| 52 | YES1 | 0.98153685 |
| 53 | MATK | 0.97097494 |
| 54 | CAMK1D | 0.95564380 |
| 55 | MARK3 | 0.95279183 |
| 56 | CHUK | 0.94611766 |
| 57 | PIM1 | 0.94153295 |
| 58 | MAP3K13 | 0.92119451 |
| 59 | FGR | 0.89897998 |
| 60 | IRAK1 | 0.89810317 |
| 61 | PTK6 | 0.89737058 |
| 62 | RPS6KA4 | 0.83482631 |
| 63 | BMPR2 | 0.82777729 |
| 64 | ERN1 | 0.82377733 |
| 65 | PDK1 | 0.80664883 |
| 66 | CAMKK2 | 0.77973501 |
| 67 | CDK8 | 0.77527489 |
| 68 | PRPF4B | 0.76487892 |
| 69 | PIK3CG | 0.75763293 |
| 70 | PAK4 | 0.75385198 |
| 71 | PRKCQ | 0.73435672 |
| 72 | IRAK2 | 0.71611105 |
| 73 | MAP3K12 | 0.70965492 |
| 74 | MAP3K3 | 0.69941239 |
| 75 | PRKCD | 0.69820332 |
| 76 | TNK2 | 0.68739290 |
| 77 | LIMK1 | 0.68544850 |
| 78 | CDK19 | 0.68165611 |
| 79 | STK4 | 0.67577740 |
| 80 | JAK2 | 0.65106385 |
| 81 | PDPK1 | 0.64632025 |
| 82 | CAMKK1 | 0.64538069 |
| 83 | FYN | 0.63911686 |
| 84 | PBK | 0.63493551 |
| 85 | MAPK12 | 0.61874415 |
| 86 | GRK1 | 0.61422937 |
| 87 | VRK1 | 0.61040392 |
| 88 | PTK2B | 0.60929471 |
| 89 | KSR2 | 0.60396655 |
| 90 | MAPK7 | 0.60307818 |
| 91 | MARK2 | 0.58871919 |
| 92 | BCKDK | 0.57834217 |
| 93 | NLK | 0.57330138 |
| 94 | PLK4 | 0.56623560 |
| 95 | EPHB1 | 0.54793112 |
| 96 | ERBB3 | 0.54404251 |
| 97 | LRRK2 | 0.53882307 |
| 98 | TNIK | 0.52066963 |
| 99 | ABL1 | 0.51895356 |
| 100 | MAP3K7 | 0.50274517 |
| 101 | STK11 | 0.50145087 |
| 102 | EIF2AK3 | 0.49311656 |
| 103 | TAOK2 | 0.46502779 |
| 104 | MAPKAPK2 | 0.45857660 |
| 105 | RPS6KA6 | 0.44441739 |
| 106 | MKNK2 | 0.44239683 |
| 107 | ATR | 0.43947212 |
| 108 | PRKCH | 0.43382887 |
| 109 | EIF2AK1 | 0.41807976 |
| 110 | HIPK2 | 0.41654657 |
| 111 | MAP3K5 | 0.41625137 |
| 112 | MAP3K6 | 0.41107043 |
| 113 | MAPK11 | 0.41040503 |
| 114 | CDK4 | 0.40492992 |
| 115 | NUAK1 | 0.40241483 |
| 116 | STK24 | 0.39899600 |
| 117 | MAP2K6 | 0.39219395 |
| 118 | SMG1 | 0.38098271 |
| 119 | FGFR3 | 0.37600839 |
| 120 | CAMK1G | 0.37483439 |
| 121 | CASK | 0.36999078 |
| 122 | RPS6KL1 | 0.36869373 |
| 123 | RPS6KC1 | 0.36869373 |
| 124 | SGK2 | 0.36217998 |
| 125 | DYRK1B | 0.35601328 |
| 126 | BRD4 | 0.35475252 |
| 127 | DAPK2 | 0.35257397 |
| 128 | EGFR | 0.34574308 |
| 129 | ABL2 | 0.33867850 |
| 130 | MOS | 0.33099672 |
| 131 | SRPK1 | 0.31783819 |
| 132 | INSRR | 0.31715586 |
| 133 | EPHA3 | 0.31317728 |
| 134 | MAP2K2 | 0.31302254 |
| 135 | FGFR4 | 0.30903291 |
| 136 | FLT3 | 0.30579193 |
| 137 | TLK1 | 0.27208432 |
| 138 | MAPK4 | 0.26440464 |
| 139 | CDK9 | 0.25965871 |
| 140 | MELK | 0.22068210 |
| 141 | PRKG2 | 0.21404594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.29401016 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.28406316 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.22304458 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.99571648 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.80554215 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.41928729 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34893007 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33610654 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.10291862 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.08716975 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.05824629 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99748130 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.84180268 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.82182847 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.79401002 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78924936 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.76406308 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72683740 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.72230756 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71971391 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69115060 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.67352609 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.63674444 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.60140290 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59356317 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.58208481 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54417708 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51666303 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45560081 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.41630814 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34424528 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33659083 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32120271 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31986064 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29042111 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.28340375 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.25523568 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20436697 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20385101 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.19348740 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15609141 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15170947 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14047675 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13844949 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10970248 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.05067792 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02087620 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.98118559 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 0.97532402 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97267288 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95227517 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94550649 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91045063 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86272605 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85450991 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85096603 |
| 57 | DNA replication_Homo sapiens_hsa03030 | 0.84014007 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83433930 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81571760 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80148833 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79874176 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79181514 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78997266 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78411664 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.75137798 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72991516 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71801248 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64768928 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62528878 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62178373 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62158640 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.59801108 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.57962003 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57641393 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57145421 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56281902 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55553465 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52660421 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50995448 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.50260330 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49248401 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48785510 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46359771 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.45569021 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44964923 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44801099 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44021502 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41683958 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40735790 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40382077 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39737748 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38891137 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38643944 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38101198 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37005724 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.36868418 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36231093 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35852194 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.34824789 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34440246 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33440782 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32999920 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32576608 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30224973 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30002385 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28694170 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28458818 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28076494 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27135919 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27026354 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26869943 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26471159 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26468481 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25979438 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.24720428 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22388988 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22204063 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.21836911 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.21532175 |
| 120 | Colorectal cancer_Homo sapiens_hsa05210 | 0.21245724 |
| 121 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.21216280 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20840288 |
| 123 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.19391959 |

